Rallybio Corp financial data

Symbol
RLYB on Nasdaq
Location
New Haven, CT
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 16 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1331% % 45%
Debt-to-equity 8.1% % -35%
Return On Assets -15% % 78%
Operating Margin -3854% % 59%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,289,675 shares -87%
Common Stock, Shares, Outstanding 5,283,321 shares 1.8%
Entity Public Float $10,600,000 USD -71%
Common Stock, Value, Issued $4,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 5,629,370 shares 3.4%
Weighted Average Number of Shares Outstanding, Diluted 5,629,370 shares 3.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $858,000 USD 35%
Research and Development Expense $19,597,000 USD -53%
General and Administrative Expense $14,325,000 USD -27%
Operating Income (Loss) $33,064,000 USD 45%
Nonoperating Income (Expense) $24,960,000 USD 403%
Net Income (Loss) Attributable to Parent $8,978,000 USD 84%
Earnings Per Share, Basic -1.59 USD/shares 85%
Earnings Per Share, Diluted -1.59 USD/shares 85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $31,374,000 USD 126%
Marketable Securities, Current $23,362,000 USD -55%
Cash, Cash Equivalents, and Short-term Investments $54,700,000 USD -16%
Other Assets, Current $2,517,000 USD 153%
Assets, Current $61,253,000 USD -9.7%
Property, Plant and Equipment, Net $23,000 USD -80%
Operating Lease, Right-of-Use Asset $175,000 USD 15%
Other Assets, Noncurrent $810,000 USD
Assets $62,261,000 USD -8.6%
Accounts Payable, Current $126,000 USD -55%
Accrued Liabilities, Current $3,791,000 USD -24%
Contract with Customer, Liability, Current $212,000 USD -75%
Liabilities, Current $4,223,000 USD -32%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $82,000 USD
Liabilities $4,305,000 USD -33%
Accumulated Other Comprehensive Income (Loss), Net of Tax $18,000 USD -74%
Retained Earnings (Accumulated Deficit) $301,998,000 USD -3.1%
Stockholders' Equity Attributable to Parent $57,956,000 USD -6%
Liabilities and Equity $62,261,000 USD -8.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,205,000 USD 34%
Net Cash Provided by (Used in) Financing Activities $0 USD
Net Cash Provided by (Used in) Investing Activities $11,081,000 USD 8%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 5,283,321 shares 1.8%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $876,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,374,000 USD 126%
Deferred Tax Assets, Valuation Allowance $100,451,000 USD 2.5%
Deferred Tax Assets, Gross $100,451,000 USD 2.5%
Operating Lease, Liability $176,000 USD 14%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $9,028,000 USD 84%
Lessee, Operating Lease, Liability, to be Paid $190,000 USD 22%
Property, Plant and Equipment, Gross $503,000 USD -35%
Operating Lease, Liability, Current $94,000 USD -39%
Lessee, Operating Lease, Liability, to be Paid, Year Two $84,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $106,000 USD -32%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14,000 USD 600%
Deferred Tax Assets, Operating Loss Carryforwards $50,322,000 USD 9.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $359,932,000 USD 1.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $5,314,000 USD -34%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%